GALEN WESLEY RADEBAUGH
Pharmacy in Chester, NJ
License number
Pennsylvania RP033433R
Category
Pharmacy
Type
Pharmacist
Address
Address
2
Chester, NJ 07930
Pennsylvania
Pennsylvania
Personal information
See more information about GALEN WESLEY RADEBAUGH at radaris.comName
Address
Phone
41 South Rd, Chester, NJ 07930
41 South Rd, Chester, NJ 07930
41 South Rd, Chester, NJ 07930
Professional information
See more information about GALEN WESLEY RADEBAUGH at trustoria.com
Process For Purified Thromboplastin For Ultra-Pure Thrombin Preparation
Process For Purified Thromboplastin For Ultra-Pure Thrombin Preparation
US Patent:
5281528, Jan 25, 1994
Filed:
Nov 6, 1992
Appl. No.:
7/973014
Inventors:
Amal Boctor - Long Valley NJ
Surendra Mehta - Randolph NJ
Galen Radebaugh - Chester NJ
Surendra Mehta - Randolph NJ
Galen Radebaugh - Chester NJ
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
C12N 948
US Classification:
435212
Abstract:
A process for the manufacture of purified thromboplastin used in the manufacture of an ultra-pure, clear thrombin solution is described.
Neutral Stabilization Complex For Ci-979 Hcl, A Cognition Activator
Neutral Stabilization Complex For Ci-979 Hcl, A Cognition Activator
US Patent:
5362860, Nov 8, 1994
Filed:
Feb 1, 1993
Appl. No.:
8/012107
Inventors:
Hua-Pin Huang - Succasunna NJ
Scott C. Wootton - Liberty Corner NJ
Thomas N. Julian - Annandale NJ
Galen W. Radebaugh - Chester NJ
Mahdi B. Fawzi - Flanders NJ
Scott C. Wootton - Liberty Corner NJ
Thomas N. Julian - Annandale NJ
Galen W. Radebaugh - Chester NJ
Mahdi B. Fawzi - Flanders NJ
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
C07G 300, C07G 1100, C07H 1500, A01N 4340
US Classification:
536 41
Abstract:
A solid composition for stabilizing the dosage of cognition activator CI-979 HCl by formation of a complex with cyclic polydextrose. In particular, compositions with HP. beta. CD have been found to stabilize CI-979 HCl even in the presence of other excipients such as sodium carbonate. Pharmaceutical formulations for the treatment of cognitive disorders in humans are based on the stabilizing composition of CI-979 HCl and cyclic polydextrose, including appropriate amounts of other excipients or components as known in the formulation art.
Oral Sustained Release Pharmaceutical Formulation And Process
Oral Sustained Release Pharmaceutical Formulation And Process
US Patent:
5004613, Apr 2, 1991
Filed:
Aug 11, 1989
Appl. No.:
7/392748
Inventors:
Galen W. Radebaugh - Chester NJ
John L. Murtha - Holland PA
Robert Glinecke - Glenside PA
John L. Murtha - Holland PA
Robert Glinecke - Glenside PA
Assignee:
McNeil-PPC, Inc. - Milltown NJ
International Classification:
A61K 922
US Classification:
424465
Abstract:
A pharmaceutical sustained release tablet or tablet layer is formed by making a wet granulation, using povidone (PVP) in water or alcohol-water as the granulating fluid which is mixed with a pharmaceutical active, hydroxyethyl cellulose, a wicking agent e. g. microcrystalline cellulose, then drying and milling the granulation and blending with dry powdered erosion promotor, e. g. pregelantinized starch, additional wicking agent, lubricant e. g. magnesium stearate and glidant e. g. silicon dioxide, and compressing the resultant granulation, which upon administration results in a slow release of the pharmaceutical active.
Soluble Calcium Lactate Antibacterial Complexes As Non-Irritating Parenteral Forms
Soluble Calcium Lactate Antibacterial Complexes As Non-Irritating Parenteral Forms
US Patent:
5290794, Mar 1, 1994
Filed:
Oct 27, 1992
Appl. No.:
7/966998
Inventors:
Surendra C. Mehta - Randolph NJ
Hua-Pin Huang - Succasunna NJ
Galen W. Radebaugh - Chester NJ
Mahdi B. Fawzi - Flanders NJ
Hua-Pin Huang - Succasunna NJ
Galen W. Radebaugh - Chester NJ
Mahdi B. Fawzi - Flanders NJ
Assignee:
Warner Lambert Co. - Morris Plains NJ
International Classification:
A61K 3144, A61K 3147
US Classification:
514300
Abstract:
Calcium lactate antibacterial complexes in parenteral dosage forms are provided that are relatively free from tissue irritation following injection, comprising a quinolone or naphthyridine.
Starch Stabilized O-Substituted Tetrahydropyridine Oxime Cholinergic Agents
Starch Stabilized O-Substituted Tetrahydropyridine Oxime Cholinergic Agents
US Patent:
5424301, Jun 13, 1995
Filed:
Feb 1, 1993
Appl. No.:
8/012108
Inventors:
Hua-Pin Huang - Succasunna NJ
Scott C. Wootton - Liberty Corner NJ
Thomas N. Julian - Annandale NJ
Galen W. Radebaugh - Chester NJ
Mahdi B. Fawzi - Flanders NJ
Scott C. Wootton - Liberty Corner NJ
Thomas N. Julian - Annandale NJ
Galen W. Radebaugh - Chester NJ
Mahdi B. Fawzi - Flanders NJ
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 31715
US Classification:
514 60
Abstract:
Solid compositions of certain cholinergic compounds are stabilized in starch. Especially compositions of corn starch combined or mixed with the 0-substituted-1,2,5,6-tetrahydro-3-pyridine oxime ether, CI-979 HCl, a cognition activator, have been found stable in a heated environment of up to 60. degree. C. over 17 days such that no losses were detected by HPLC analysis. A solid peroral pharmaceutical formulation for the treatment of cognitive disorders is based on the bicomponent composition of active ingredient and stabilizer using appropriate amounts of other excipients or components known in the formulation art.
Ultra-Pure Thrombin Preparation
Ultra-Pure Thrombin Preparation
US Patent:
5397704, Mar 14, 1995
Filed:
Oct 12, 1993
Appl. No.:
8/135039
Inventors:
Amal Boctor - Long Valley NJ
Surendra Mehta - Randolph NJ
Galen Radebaugh - Chester NJ
Surendra Mehta - Randolph NJ
Galen Radebaugh - Chester NJ
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
C12N 974, C12N 948, A61K 37547, C07K 1300
US Classification:
435214
Abstract:
An ultra-pure, clear thrombin solution having a high specific activity is described as well as a method of manufacture.
Peripheral Opioid Receptor Antagonists And Uses Thereof
Peripheral Opioid Receptor Antagonists And Uses Thereof
US Patent:
8420663, Apr 16, 2013
Filed:
Aug 9, 2012
Appl. No.:
13/570836
Inventors:
Nataliya Bazhina - Tappan NY, US
Steven R. Fabian - Barnegat NJ, US
John Lokhnauth - Fair Lawn NJ, US
Sreenivasulu Megati - New City NY, US
Charles K. Melucci - Highland Mills NY, US
Christian Ofslager - Newburgh NY, US
Niketa Patel - Lincoln Park NJ, US
Galen Radebaugh - Chester NJ, US
Syed M. Shah - East Hanover NJ, US
Jan Szeliga - Croton on Hudson NY, US
Huyi Zhang - Garnerville NY, US
Tianmin Zhu - Monroe NY, US
Steven R. Fabian - Barnegat NJ, US
John Lokhnauth - Fair Lawn NJ, US
Sreenivasulu Megati - New City NY, US
Charles K. Melucci - Highland Mills NY, US
Christian Ofslager - Newburgh NY, US
Niketa Patel - Lincoln Park NJ, US
Galen Radebaugh - Chester NJ, US
Syed M. Shah - East Hanover NJ, US
Jan Szeliga - Croton on Hudson NY, US
Huyi Zhang - Garnerville NY, US
Tianmin Zhu - Monroe NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/485, A61K 31/4748
US Classification:
514282, 514289
Abstract:
The present invention provides a compound of formula I:.
Peripheral Opioid Receptor Antagonists And Uses Thereof
Peripheral Opioid Receptor Antagonists And Uses Thereof
US Patent:
8455644, Jun 4, 2013
Filed:
Jul 11, 2012
Appl. No.:
13/546500
Inventors:
Nataliya Bazhina - Tappan NY, US
Steven R. Fabian - Barnegat NJ, US
John Lokhnauth - Fair Lawn NJ, US
Sreenivasulu Megati - New City NY, US
Charles Melucci - Highland Mills NY, US
Christian Ofslager - Newburgh NY, US
Niketa Patel - Lincoln Park NJ, US
Galen Radebaugh - Chester NJ, US
Syed M. Shah - East Hanover NJ, US
Jan Szeliga - Croton on Hudson NY, US
Huyi Zhang - Garnerville NY, US
Tianmin Zhu - Monroe NY, US
Steven R. Fabian - Barnegat NJ, US
John Lokhnauth - Fair Lawn NJ, US
Sreenivasulu Megati - New City NY, US
Charles Melucci - Highland Mills NY, US
Christian Ofslager - Newburgh NY, US
Niketa Patel - Lincoln Park NJ, US
Galen Radebaugh - Chester NJ, US
Syed M. Shah - East Hanover NJ, US
Jan Szeliga - Croton on Hudson NY, US
Huyi Zhang - Garnerville NY, US
Tianmin Zhu - Monroe NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
C07D 221/22, C07D 489/08
US Classification:
546 74, 546 45
Abstract:
The present invention provides a compound of formula I:.
Peripheral Opioid Receptor Antagonists And Uses Thereof
Peripheral Opioid Receptor Antagonists And Uses Thereof
US Patent:
2014008, Mar 20, 2014
Filed:
May 2, 2013
Appl. No.:
13/875657
Inventors:
Steven R. Fabian - Barnegat NJ, US
John Lokhnauth - Fair Lawn NJ, US
Sreenivasulu Megati - New City NY, US
Charles Melucci - Highland Mills NY, US
Christian Ofslager - Newburgh NY, US
Niketa Patel - Lincoln Park NJ, US
Galen Radebaugh - Chester NJ, US
Syed M. Shah - East Hanover NJ, US
Jan Szeliga - Croton On Hudson NY, US
Huyi Zhang - Garnerville NY, US
Tianmin Zhu - Monroe NY, US
John Lokhnauth - Fair Lawn NJ, US
Sreenivasulu Megati - New City NY, US
Charles Melucci - Highland Mills NY, US
Christian Ofslager - Newburgh NY, US
Niketa Patel - Lincoln Park NJ, US
Galen Radebaugh - Chester NJ, US
Syed M. Shah - East Hanover NJ, US
Jan Szeliga - Croton On Hudson NY, US
Huyi Zhang - Garnerville NY, US
Tianmin Zhu - Monroe NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/485
US Classification:
514282
Abstract:
The present invention provides a compound of formula I:wherein X, R, and Rare as defined herein, and compositions thereof.
Process For Preparing An Ultra-Pure Thrombin Preparation
Process For Preparing An Ultra-Pure Thrombin Preparation
US Patent:
5525498, Jun 11, 1996
Filed:
Feb 22, 1991
Appl. No.:
7/657427
Inventors:
Amal Boctor - Long Valley NJ
Surendra Mehta - Randolph NJ
Galen Radebaugh - Chester NJ
Surendra Mehta - Randolph NJ
Galen Radebaugh - Chester NJ
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
C12N 974
US Classification:
435214
Abstract:
An ultra-pure, clear thrombin solution having a high specific activity is described as well as a method of manufacture.